Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing [Yahoo! Finance]
Psyence Biomedical Ltd. - Ordinary Shares (PBM)
Company Research
Source: Yahoo! Finance
outcome of the Nasdaq Listing Qualifications Hearing that was held on October 31 st , 2024. The Nasdaq Hearings Panel has granted Psyence Biomed an extension until December 31 st , 2024, to demonstrate compliance with all Nasdaq continued listing rules. During the Company's Nasdaq Listing Qualifications Hearing, Psyence Biomed presented a comprehensive plan to regain and maintain compliance with Nasdaq's continued listing requirements, including 5550(a)(2), the $1 minimum bid price requirement, 5550(a)(5), the $1.0 million minimum market value of publicly held shares requirement, and 5550(b)(1), the $2.5 million minimum stockholders' equity requirement. As part of its plan, Psyence Biomed requested to be transferred from The Nasdaq Global Market to The Nasdaq Capital Market pursuant to a Panel exception, effective November 15 th , 2024. Furthermore, as previously announced, Psyence Biomed obtained shareholder approval during its Annual General Meeting on November 12 th , 2024, to
Show less
Read more
Impact Snapshot
Event Time:
PBM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PBM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PBM alerts
High impacting Psyence Biomedical Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
PBM
News
- Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications HearingGlobeNewswire
- Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation [Canadian Business Journal (Canada)]Canadian Business Journal
- Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation [Yahoo! Finance]Yahoo! Finance
- Psyence Biomedical Announces Effective Date for 1-for-75 Share ConsolidationGlobeNewswire
- Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from NasdaqGlobeNewswire
PBM
Sec Filings
- 11/22/24 - Form 6-K
- 11/13/24 - Form SC
- 11/12/24 - Form 6-K
- PBM's page on the SEC website